Evidence map›Paper›PMID 31641056›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2019

ApoE4 Alters ABCA1 Membrane Trafficking in Astrocytes.

Varun Rawat, Shaowei Wang, Jian Sima, Roni Bar, Ori Liraz, Usha Gundimeda, Trusha Parekh, Jamie Chan, Jan O Johansson, Chongren Tang and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 100 papers.

0numbers the graph read from it
0cells of the map it votes in
100citing papers in PubMed
14.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

100 citing papers in PubMed, 175 citations in OpenAlex.

  1. Trial
  2. ApoE lipidation state directs immunometabolic reprogramming of human microglia.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. APOE-Targeted Therapeutics for Alzheimer's Disease.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2025
    Review
  16. Review
  17. Review
  18. Article
  19. Proteomic and metabolic profiling revealsbioRxiv : the preprint server for biology · 2025
    Article
  20. Review

40 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 2 countries.

Varun RawatUniversity of Southern California, Los Angeles, California, 90033.
Shaowei WangUniversity of Southern California, Los Angeles, California, 90033.
Jian SimaUniversity of Southern California, Los Angeles, California, 90033.
Roni BarTel Aviv University, Tel Aviv 6997801, Israel.
Ori LirazTel Aviv University, Tel Aviv 6997801, Israel.
Usha GundimedaUniversity of Southern California, Los Angeles, California, 90033.
Trusha ParekhUniversity of Southern California, Los Angeles, California, 90033.
Jamie ChanUniversity of Southern California, Los Angeles, California, 90033.
Jan O JohanssonArtery Therapeutics, Inc., San Ramon, California 94583.
Chongren TangUniversity of Washington, Seattle, Washington 98195, and.
Helena C ChuiUniversity of Southern California, Los Angeles, California, 90033.
Michael G HarringtonHuntington Medical Research Institute, Pasadena, California 91105.
Daniel M MichaelsonTel Aviv University, Tel Aviv 6997801, Israel.
Hussein N YassineUniversity of Southern California, Los Angeles, California, 90033, hyassine@usc.edu.
University of Southern California · USTel Aviv University · ILEureka Therapeutics (United States) · USHuntington Medical Research Institutes · USUniversity of Washington · US

Funding

VASCULAR RISK AND COGNITIVE STATUS IN A LATINO POPULATIONP50AG005142 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI ARANDA, MARIA P. · 1985 to 2019
$41.0M
USC RESEARCH CENTER FOR LIVER DISEASES: PILOT PROGRAMSP30DK048522 · NIDDK · UNIVERSITY OF SOUTHERN CALIFORNIA · PI KAPLOWITZ, NEIL · 1995 to 2020
$21.8M
The delivery of essential fatty acids to the Brain in Alzheimer's diseaseR01AG054434 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI YASSINE, HUSSEIN N · 2017 to 2021
$5.4M
Biomarkers of ABCA1 mediated functions in Alzheimers diseaseR01AG055770 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI YASSINE, HUSSEIN N · 2017 to 2021
$4.2M
DHA brain delivery by APOE genotypeR21AG056518 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI YASSINE, HUSSEIN N · 2018 to 2019
$464k
NIA NIH HHS P50 AG005142NIA NIH HHS R01 AG054434NIA NIH HHS R01 AG055770NIA NIH HHS R21 AG056518NIDDK NIH HHS P30 DK048522
6 · The paper itself

Abstract

The

Indexed as

ADP-Ribosylation Factor 6AgedAged, 80 and overAnimalsApolipoprotein E4AstrocytesATP Binding Cassette Transporter 1Cell Line, TransformedCell MembraneCells, CulturedCricetinaeFemaleHeLa CellsHumansMaleMiceAbca1 protein, mouseADP-Ribosylation Factor 6Apolipoprotein E4ARF6 protein, humanArf6 protein, mouseATP Binding Cassette Transporter 1ABCA1aggregationAlzheimer's diseaseApoElipids

Identifiers

PMID31641056
PMCPMC6880458
OpenAlexW2981813975

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.